Paradigm is revolutionizing clinical research by creating a more efficient and equitable ecosystem for patient care. Their platform addresses the current challenges in clinical trials, which are often seen as fragmented and burdensome for both patients and providers. By integrating clinical trials into the existing workflows of healthcare providers, Paradigm enhances patient access to therapeutic options, particularly for those facing serious diseases like cancer and rare conditions. This innovative approach not only streamlines the recruitment process but also ensures that diverse and representative patient populations can participate in trials without having to leave their local care environments.

The company employs advanced technology, including AI-powered software, to facilitate an end-to-end clinical operating model that encompasses trial design, site selection, patient recruitment, and data collection. This comprehensive system reduces the administrative burden on healthcare providers and accelerates the overall trial process. By automating data collection and integrating with electronic medical records (EMR), Paradigm enhances data quality and reduces costs associated with monitoring. Their commitment to embedding clinical trials within routine care not only improves operational efficiency but also significantly increases patient participation rates, ultimately transforming the landscape of clinical research.

United States

Paradigm Health is rebuilding the clinical research ecosystem by creating a platform that enables equitable access to trials for all patients, while enhancing trial efficiency and reducing the barriers to participation for healthcare providers. Incubated by ARCH Venture Partners and backed by leading healthcare and life sciences investors, Paradigm Health aims to break down barriers across the trial ecosystem through one seamless infrastructure implemented at healthcare provider organizations, bringing potentially life-saving therapies to patients faster.

Paradigm

Company Details